Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack | Zendy

S. Claiborne Johnston | Zendy; Pierre Amarenco | Zendy; Gregory W. Albers | Zendy; Hans Denison | Zendy; J. Donald Easton | Zendy; Scott R. Evans | Zendy; Peter Held | Zendy; Jenny Jonasson | Zendy; Kazuo Minematsu | Zendy; Carlos A. Molina | Zendy; Yongjun Wang | Zendy; Ka Sing Wong | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack

Author(s) -

S. Claiborne Johnston,

Pierre Amarenco,

Gregory W. Albers,

Hans Denison,

J. Donald Easton,

Scott R. Evans,

Peter Held,

Jenny Jonasson,

Kazuo Minematsu,

Carlos A. Molina,

Yongjun Wang,

Ka Sing Wong

Publication year - 2016

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1603060

Subject(s) - medicine , ticagrelor , aspirin , hazard ratio , stroke (engine) , thrombolysis , myocardial infarction , cardiology , clinical endpoint , anesthesia , confidence interval , randomized controlled trial , clopidogrel , mechanical engineering , engineering

Ticagrelor may be a more effective antiplatelet therapy than aspirin for the prevention of recurrent stroke and cardiovascular events in patients with acute cerebral ischemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research